| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824562 | Clinical Therapeutics | 2016 | 16 Pages |
Abstract
The findings from the present study suggest that, for maintaining the optimal target Hb concentration (10-12 g/dL according to the current summary of product characteristics for epoetin theta; 10-11.5 g/dL according to the current guideline from Kidney Disease Improving Global Outcomes) in anemic adults with CKD, the lowest approved, effective dose epoetin theta should be used.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Andreas MD, Peter MD, Peter MD, Simone Mangold, Martin MD,